NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula (1) in which the radicals and symbols have the meanings indicated in the claims and to pharmaceutically acceptable salts thereof. Compounds of formula (1) are ERK inhibitors..EFFECT: invention also relates to a pharmaceutical comp...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FEVRIER Salem KOZLOVSKI Dzhozef LIPFORD Ketrin MALETIK Milana M CHEN Lej METOT Dzhoi L MANSUR Umar Faruk BAKSHI Raman Kumar SHINKRE Bidkhan A LIM Chzhongvon TUN Lin UILSON Kevin Dzh KARUNAKARAN Ganesh Babu O'BOJL Brendan SILIPKHAIVANKH Pkhieng BOJS Kristofer DENIELS Mettyu KH KHUAN Syankhaj SLOMAN Devid TKHATAJ Dzhayantkh Tkhiruvellore FALKONE Deniell KURUKULASURIYA Ravi UITTER Devid Dzh CHZHOU Vej |
| description | FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula (1) in which the radicals and symbols have the meanings indicated in the claims and to pharmaceutically acceptable salts thereof. Compounds of formula (1) are ERK inhibitors..EFFECT: invention also relates to a pharmaceutical composition comprising and to methods for treating malignant neoplasms using a compound of formula (1).16 cl, 6 tbl, 458 ex
Изобретение относится к соединениям формулы (1), в которой радикалы и символы имеют значения, указанные в формуле изобретения, и к их фармацевтически приемлемым солям. Соединения формулы (1) являются ингибиторами ERK. Изобретение также относится к фармацевтической композиции их содержащей и к способам лечения злокачественных новообразований с использованием соединения формулы (1). 4 н. и 12 з.п. ф-лы, 6 табл., 458 пр. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2660429C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2660429C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2660429C23</originalsourceid><addsrcrecordid>eNrjZFD38w9z9VFw9vcN8A_1cwlWCPFwDFFwDHJVcA3yVvD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxQaFGZmYGJkaWzkbGRCgBAKcVI5w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><source>esp@cenet</source><creator>FEVRIER Salem ; KOZLOVSKI Dzhozef ; LIPFORD Ketrin ; MALETIK Milana M ; CHEN Lej ; METOT Dzhoi L ; MANSUR Umar Faruk ; BAKSHI Raman Kumar ; SHINKRE Bidkhan A ; LIM Chzhongvon ; TUN Lin ; UILSON Kevin Dzh ; KARUNAKARAN Ganesh Babu ; O'BOJL Brendan ; SILIPKHAIVANKH Pkhieng ; BOJS Kristofer ; DENIELS Mettyu KH ; KHUAN Syankhaj ; SLOMAN Devid ; TKHATAJ Dzhayantkh Tkhiruvellore ; FALKONE Deniell ; KURUKULASURIYA Ravi ; UITTER Devid Dzh ; CHZHOU Vej</creator><creatorcontrib>FEVRIER Salem ; KOZLOVSKI Dzhozef ; LIPFORD Ketrin ; MALETIK Milana M ; CHEN Lej ; METOT Dzhoi L ; MANSUR Umar Faruk ; BAKSHI Raman Kumar ; SHINKRE Bidkhan A ; LIM Chzhongvon ; TUN Lin ; UILSON Kevin Dzh ; KARUNAKARAN Ganesh Babu ; O'BOJL Brendan ; SILIPKHAIVANKH Pkhieng ; BOJS Kristofer ; DENIELS Mettyu KH ; KHUAN Syankhaj ; SLOMAN Devid ; TKHATAJ Dzhayantkh Tkhiruvellore ; FALKONE Deniell ; KURUKULASURIYA Ravi ; UITTER Devid Dzh ; CHZHOU Vej</creatorcontrib><description>FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula (1) in which the radicals and symbols have the meanings indicated in the claims and to pharmaceutically acceptable salts thereof. Compounds of formula (1) are ERK inhibitors..EFFECT: invention also relates to a pharmaceutical composition comprising and to methods for treating malignant neoplasms using a compound of formula (1).16 cl, 6 tbl, 458 ex
Изобретение относится к соединениям формулы (1), в которой радикалы и символы имеют значения, указанные в формуле изобретения, и к их фармацевтически приемлемым солям. Соединения формулы (1) являются ингибиторами ERK. Изобретение также относится к фармацевтической композиции их содержащей и к способам лечения злокачественных новообразований с использованием соединения формулы (1). 4 н. и 12 з.п. ф-лы, 6 табл., 458 пр.</description><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180706&DB=EPODOC&CC=RU&NR=2660429C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180706&DB=EPODOC&CC=RU&NR=2660429C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FEVRIER Salem</creatorcontrib><creatorcontrib>KOZLOVSKI Dzhozef</creatorcontrib><creatorcontrib>LIPFORD Ketrin</creatorcontrib><creatorcontrib>MALETIK Milana M</creatorcontrib><creatorcontrib>CHEN Lej</creatorcontrib><creatorcontrib>METOT Dzhoi L</creatorcontrib><creatorcontrib>MANSUR Umar Faruk</creatorcontrib><creatorcontrib>BAKSHI Raman Kumar</creatorcontrib><creatorcontrib>SHINKRE Bidkhan A</creatorcontrib><creatorcontrib>LIM Chzhongvon</creatorcontrib><creatorcontrib>TUN Lin</creatorcontrib><creatorcontrib>UILSON Kevin Dzh</creatorcontrib><creatorcontrib>KARUNAKARAN Ganesh Babu</creatorcontrib><creatorcontrib>O'BOJL Brendan</creatorcontrib><creatorcontrib>SILIPKHAIVANKH Pkhieng</creatorcontrib><creatorcontrib>BOJS Kristofer</creatorcontrib><creatorcontrib>DENIELS Mettyu KH</creatorcontrib><creatorcontrib>KHUAN Syankhaj</creatorcontrib><creatorcontrib>SLOMAN Devid</creatorcontrib><creatorcontrib>TKHATAJ Dzhayantkh Tkhiruvellore</creatorcontrib><creatorcontrib>FALKONE Deniell</creatorcontrib><creatorcontrib>KURUKULASURIYA Ravi</creatorcontrib><creatorcontrib>UITTER Devid Dzh</creatorcontrib><creatorcontrib>CHZHOU Vej</creatorcontrib><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><description>FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula (1) in which the radicals and symbols have the meanings indicated in the claims and to pharmaceutically acceptable salts thereof. Compounds of formula (1) are ERK inhibitors..EFFECT: invention also relates to a pharmaceutical composition comprising and to methods for treating malignant neoplasms using a compound of formula (1).16 cl, 6 tbl, 458 ex
Изобретение относится к соединениям формулы (1), в которой радикалы и символы имеют значения, указанные в формуле изобретения, и к их фармацевтически приемлемым солям. Соединения формулы (1) являются ингибиторами ERK. Изобретение также относится к фармацевтической композиции их содержащей и к способам лечения злокачественных новообразований с использованием соединения формулы (1). 4 н. и 12 з.п. ф-лы, 6 табл., 458 пр.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD38w9z9VFw9vcN8A_1cwlWCPFwDFFwDHJVcA3yVvD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxQaFGZmYGJkaWzkbGRCgBAKcVI5w</recordid><startdate>20180706</startdate><enddate>20180706</enddate><creator>FEVRIER Salem</creator><creator>KOZLOVSKI Dzhozef</creator><creator>LIPFORD Ketrin</creator><creator>MALETIK Milana M</creator><creator>CHEN Lej</creator><creator>METOT Dzhoi L</creator><creator>MANSUR Umar Faruk</creator><creator>BAKSHI Raman Kumar</creator><creator>SHINKRE Bidkhan A</creator><creator>LIM Chzhongvon</creator><creator>TUN Lin</creator><creator>UILSON Kevin Dzh</creator><creator>KARUNAKARAN Ganesh Babu</creator><creator>O'BOJL Brendan</creator><creator>SILIPKHAIVANKH Pkhieng</creator><creator>BOJS Kristofer</creator><creator>DENIELS Mettyu KH</creator><creator>KHUAN Syankhaj</creator><creator>SLOMAN Devid</creator><creator>TKHATAJ Dzhayantkh Tkhiruvellore</creator><creator>FALKONE Deniell</creator><creator>KURUKULASURIYA Ravi</creator><creator>UITTER Devid Dzh</creator><creator>CHZHOU Vej</creator><scope>EVB</scope></search><sort><creationdate>20180706</creationdate><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><author>FEVRIER Salem ; KOZLOVSKI Dzhozef ; LIPFORD Ketrin ; MALETIK Milana M ; CHEN Lej ; METOT Dzhoi L ; MANSUR Umar Faruk ; BAKSHI Raman Kumar ; SHINKRE Bidkhan A ; LIM Chzhongvon ; TUN Lin ; UILSON Kevin Dzh ; KARUNAKARAN Ganesh Babu ; O'BOJL Brendan ; SILIPKHAIVANKH Pkhieng ; BOJS Kristofer ; DENIELS Mettyu KH ; KHUAN Syankhaj ; SLOMAN Devid ; TKHATAJ Dzhayantkh Tkhiruvellore ; FALKONE Deniell ; KURUKULASURIYA Ravi ; UITTER Devid Dzh ; CHZHOU Vej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2660429C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FEVRIER Salem</creatorcontrib><creatorcontrib>KOZLOVSKI Dzhozef</creatorcontrib><creatorcontrib>LIPFORD Ketrin</creatorcontrib><creatorcontrib>MALETIK Milana M</creatorcontrib><creatorcontrib>CHEN Lej</creatorcontrib><creatorcontrib>METOT Dzhoi L</creatorcontrib><creatorcontrib>MANSUR Umar Faruk</creatorcontrib><creatorcontrib>BAKSHI Raman Kumar</creatorcontrib><creatorcontrib>SHINKRE Bidkhan A</creatorcontrib><creatorcontrib>LIM Chzhongvon</creatorcontrib><creatorcontrib>TUN Lin</creatorcontrib><creatorcontrib>UILSON Kevin Dzh</creatorcontrib><creatorcontrib>KARUNAKARAN Ganesh Babu</creatorcontrib><creatorcontrib>O'BOJL Brendan</creatorcontrib><creatorcontrib>SILIPKHAIVANKH Pkhieng</creatorcontrib><creatorcontrib>BOJS Kristofer</creatorcontrib><creatorcontrib>DENIELS Mettyu KH</creatorcontrib><creatorcontrib>KHUAN Syankhaj</creatorcontrib><creatorcontrib>SLOMAN Devid</creatorcontrib><creatorcontrib>TKHATAJ Dzhayantkh Tkhiruvellore</creatorcontrib><creatorcontrib>FALKONE Deniell</creatorcontrib><creatorcontrib>KURUKULASURIYA Ravi</creatorcontrib><creatorcontrib>UITTER Devid Dzh</creatorcontrib><creatorcontrib>CHZHOU Vej</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FEVRIER Salem</au><au>KOZLOVSKI Dzhozef</au><au>LIPFORD Ketrin</au><au>MALETIK Milana M</au><au>CHEN Lej</au><au>METOT Dzhoi L</au><au>MANSUR Umar Faruk</au><au>BAKSHI Raman Kumar</au><au>SHINKRE Bidkhan A</au><au>LIM Chzhongvon</au><au>TUN Lin</au><au>UILSON Kevin Dzh</au><au>KARUNAKARAN Ganesh Babu</au><au>O'BOJL Brendan</au><au>SILIPKHAIVANKH Pkhieng</au><au>BOJS Kristofer</au><au>DENIELS Mettyu KH</au><au>KHUAN Syankhaj</au><au>SLOMAN Devid</au><au>TKHATAJ Dzhayantkh Tkhiruvellore</au><au>FALKONE Deniell</au><au>KURUKULASURIYA Ravi</au><au>UITTER Devid Dzh</au><au>CHZHOU Vej</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><date>2018-07-06</date><risdate>2018</risdate><abstract>FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula (1) in which the radicals and symbols have the meanings indicated in the claims and to pharmaceutically acceptable salts thereof. Compounds of formula (1) are ERK inhibitors..EFFECT: invention also relates to a pharmaceutical composition comprising and to methods for treating malignant neoplasms using a compound of formula (1).16 cl, 6 tbl, 458 ex
Изобретение относится к соединениям формулы (1), в которой радикалы и символы имеют значения, указанные в формуле изобретения, и к их фармацевтически приемлемым солям. Соединения формулы (1) являются ингибиторами ERK. Изобретение также относится к фармацевтической композиции их содержащей и к способам лечения злокачественных новообразований с использованием соединения формулы (1). 4 н. и 12 з.п. ф-лы, 6 табл., 458 пр.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2660429C2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | NOVEL COMPOUNDS THAT ARE ERK INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A17%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FEVRIER%20Salem&rft.date=2018-07-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2660429C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |